BioDtech, Inc.
1 known investors
Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $979.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does BioDtech, Inc. do?
- Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.
- Who are BioDtech, Inc.'s investors?
- BioDtech, Inc.'s investors include Targeted Technology Funds.